Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
142,928,596
-
Share change
-
+37,104,171
-
Total reported value
-
$155,860,863
-
Put/Call ratio
-
45%
-
Price per share
-
$1.09
-
Number of holders
-
155
-
Value change
-
+$39,717,323
-
Number of buys
-
65
-
Number of sells
-
72
Institutional Holders of ZIOPHARM ONCOLOGY INC - COM (TCRT) as of Q4 2021
As of 31 Dec 2021,
ZIOPHARM ONCOLOGY INC - COM (TCRT) was held by
155 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
142,928,596 shares.
The largest 10 holders included
MSD Partners, L.P., BlackRock Inc., DISCOVERY CAPITAL MANAGEMENT, LLC / CT, STATE STREET CORP, VANGUARD GROUP INC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, and NORTHERN TRUST CORP.
This page lists
155
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.